May 16th, 2023 (Shanghai) — We are glad to announce that Jennifer Chow, the CEO of Chimeric Therapeutics, has been invited to present at ACCESS CHINA Boston Forum during June 4th – 14th. ACCESS CHINA Biotech Forum is the largest corporate access event between Asia and the western biopharma industry.
Please contact us if you would like to have 1 on 1 meeting with Chimeric Therapeutics.
About Chimeric Therapeutics
Chimeric Therapeutics is a clinical stage cell therapy company focused on bringing the promise of cell therapy to life for more patients with cancer.
Chimeric believes that cellular therapies have the promise to cure cancer not just delay disease progression.
To bring that promise to life for more patients, Chimeric’s world class team of cell therapy pioneers and experts is focused on the discovery, development and commercialization of the most innovative and promising cell therapies.
About the speaker
Jennifer Chow is the Chief Executive Officer and Managing Director of Chimeric Therapeutics. Jennifer is a cell therapy pioneer and expert with experience developing and commercializing FDA approved CAR T cell therapies, Abecma™, Breyzani™, Yescarta™ and Tecartus™. Jennifer also has experience leading the commercial development for more than 15 pipeline cell therapies.
Jennifer joined Chimeric from Kite Pharmaceuticals where she was the Head of Global Marketing, Analytics and Commercial Operations and was responsible for optimizing the commercial development of all Kite pipeline therapies.
Prior to Kite, Jennifer was the Global Cell Therapy Commercial Lead at Celgene Corporation defining the global commercial strategy and operating model for Celgene cell therapies.
Jennifer has developed over 10 oncology therapeutics for launch and has more than 20 years’ experience in the biotech and pharmaceutical field.
About ACCESS CHINA Boston Forum
“ACCESS CHINA – Boston Forum @BIO” is scheduled to be held on June 4th and June 13th-15th, 2023, in Boston and online, respectively. This event is expected to be the largest Asia-themed gathering during the BIO Convention 2023. The main theme of the forum is “Building Effective Partnerships in Asia: Strategies for Collaboration and Growth”. During the forum, we will cover a range of key topics include drug innovation, market trends, partnership models, and best practices for successful collaborations, etc.
Conference Name: ACCESS CHINA – Boston Forum @BIO
Date & Time: June 4, Sun. (Boston) and June 13-15 (Online)
Content: Keynote Speeches, Panel Discussion, Company Presentations, ChemPartner-ACCESS CHINA Dinner Reception
Scale: Expected 1000 participants Online, 150 participants onsite; 100 company roadshows
Participants: Pharma/Biotech senior management and BDs, investors.
View more information at https://biotochina.org/
关于药通中国-波士顿论坛
“ACCESS CHINA 药通中国-波士顿论坛@BIO”将于2023年6月4-15日在波士顿及线上举行的。此次论坛将是BIO Convention 2023大会期间最大的亚洲主题交流活动。在过去3年时间，药通中国已成功举办13届线上线下活动，帮助近千家公司在药通平台上展出。
大会名称：药通中国-波士顿论坛@BIO
大会日期：2023.6.4（周日，波士顿） 2023.6.13-15（线上）
大会内容：主题演讲、圆桌讨论、海内外优质项目路演、睿智医药-药通中国招待晚宴
大会规模：预计线上1000参会者； 线下150参会者; 100场公司路演
参会观众：海内外医药企业（药企及Biotech）高管及BD、基金高管
查看更多信息： https://biotochina.org/
MORE INFORMATION
Contact US
Register ACCESS CHINA online, please visit: ACCESS CHINA Biotech Forum
For more information, please contact:
Wendi Xiang
Wxiang@yafocapital.com
BioToChina.org 